|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
The patient's attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced defective mesh, infection, necrosis, adhesions, serosal tear, recurrence, scarring, pain, mental pain, impairment, loss of enjoyment of life.Post-operative patient treatment included removal of mesh, hernia repair with new mesh, wound washout, lysis of adhesions, debridement of necrotic tissue, repair of serosal tear, small bowel resection, partial omentectomy, fascial closure, wound vac.
|